All In MedTech

Device Trial Radar · NCT04607369

Implementation of the NEDS EyeCTester App

Implementation of the NEDS EyeCTester App and NEDS Server Analysis Software Into the Homes of Patients With Neuro-ophthalmic, Retinal and Other Diseases to Enhance Early Detection of Active Eye Disease.

Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

100

Planned (sponsor's estimate)

Start

Jan 9, 2019

Primary completion

Dec 31, 2027

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Neuro-Eye Diagnostic Systems, LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Neuro-Ophthalmology of Texas
First posted
Oct 29, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Group 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app. Group 7a and 7b was an FDA trial that showed that normal patients do not have false positives on the Amsler app as well as on the Amsler paper version. Further Vision on the app is slightly better than vision on the standard Sloan near card using a formula (vision is 7/10th of a line better on the app).

Conditions

  • Optic Nerve Disease
  • Macular Disease
  • Visual Pathway Disorder

Interventions

  • EyeCTesterDevice

    Smartphone app that allows vision testing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Outcome Measure for Groups 4a and 4b:Time frame: Study was conducted for each patient in one day.

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neuro-ophthalmology of Texas, PLLC

    Bellaire, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.